Pregabalin Capsule
Product Images NDC 71610-926

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71610-926). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (71610 0926 30)

Label (71610 0926 30)
FDA Label Image

Aphena (Aphena)

Aphena (Aphena)
FDA Label Image

Chemical Structure (Pregabalin 01)

Chemical Structure (Pregabalin 01)
FDA Label Image

Figure 1 (Pregabalin 02)

Figure 1 (Pregabalin 02)
FDA Label Image

Figure 2 (Pregabalin 03)

Figure 2 (Pregabalin 03)
Not available.*
FDA Label Image

Figure 3 (Pregabalin 04)

Figure 3 (Pregabalin 04)
FDA Label Image

Figure 4 (Pregabalin 05)

Figure 4 (Pregabalin 05)
FDA Label Image

Figure 5 (Pregabalin 06)

Figure 5 (Pregabalin 06)
This appears to be a medication dosage chart displaying the percentage of patients who improved with Pregabalin at 100mg and 80mg three times a day compared to a placebo. The chart also shows the percentage of improvement in pain from the baseline.*
FDA Label Image

Figure 6 (Pregabalin 07)

Figure 6 (Pregabalin 07)
FDA Label Image

Figure 7 (Pregabalin 08)

Figure 7 (Pregabalin 08)
FDA Label Image

Figure 8 (Pregabalin 09)

Figure 8 (Pregabalin 09)
This is a data set consisting of responder rates for different treatments. The responder rates are listed as percentages for the treatments "Placebo," "2.5 mg/kg/day," and "10 mg/kg/day." The values range from 22.6% to 40.6%.*
FDA Label Image

Figure 9 (Pregabalin 10)

Figure 9 (Pregabalin 10)
This is a chart showing the percentage of patients who experienced improvement in pain after taking different doses of a medication named Preguissin. It indicates that 100% of patients showed improvement after taking a 4807 car dose of Pregoain, while the percentage of improvement is not specified for the other doses mentioned. The document also includes information on the percent improvement in pain from the baseline.*
FDA Label Image

Figure 10 (Pregabalin 11)

Figure 10 (Pregabalin 11)
FDA Label Image

Figure 11 (Pregabalin 12)

Figure 11 (Pregabalin 12)
The text provides information on the percentage of subjects showing improvement over time, specifically from baseline to week 12. It mentions the usage of Pregabalin in this context. The data points mentioned include percentages like 20, 90, and 100.*
FDA Label Image

Figure 12 (Pregabalin 13)

Figure 12 (Pregabalin 13)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.